Risk analysis for outpatient experimental infection as a pathway for affordable RSV vaccine development
E Z Siegal, J M H Schoevers, J Terstappen, E M Delemarre, S L Johnston, L F van Beek, D Bogaert, C Chiu, D A Diavatopoulos, D M Ferreira, S B Gordon, F G Hayden, M I de Jonge, M B B McCall, H I McShane, A M Minassian, P J M Openshaw, A J Pollard, J Sattabongkot, R C Read, A Troelstra, M C Viveen, A Wilder-Smith, M van Wijk, L J Bont, N I Mazur
npj Vaccines, 2025, vol. 10
RSM01, a novel respiratory syncytial virus monoclonal antibody
Aurelio Bonavia, Micha Levi, Harald Rouha, Adriana Badarau, Jonne Terstappen, Shayne Watson, Aparna B. Anderson, Joleen T. White, Jintanat Ananworanich, Dale Taylor, Andrijana Radivojevic, Michael Shaffer, Luisa M. Stamm, Michael W. Dunne
BMC Infectious Diseases, 2024, vol. 24
The respiratory syncytial virus vaccine and monoclonal antibody landscape
Jonne Terstappen, Sarah F. Hak, Anant Bhan, Debby Bogaert, Louis J. Bont, Ursula J. Buchholz, Andrew D. Clark, Cheryl Cohen, Ron Dagan, Daniel R. Feikin, Barney S. Graham, Anuradha Gupta, Pradeep Haldar, Rose Jalang'o, Ruth A. Karron, Leyla Kragten, You Li, Yvette N. Löwensteyn, Patrick K. Munywoki, Rosemary Njogu, Ab Osterhaus, Andrew J. Pollard, Luiza Reali Nazario, Charles Sande, Ashish R. Satav, Padmini Srikantiah, Renato T. Stein, Naveen Thacker, Rachael Thomas, Marta Tufet Bayona, Natalie I. Mazur
The Lancet Infectious Diseases, 2024, vol. 24, p.e747-e761
